Overall survival of patients with KIT-mutant metastatic GIST in the era of multiple kinase inhibitor availability
Abstract Purpose The prognosis of patients with metastatic GIST and imatinib-sensitive primary mutations has significantly improved. However, limited data are available to inform patients about outcomes across different lines of treatment. This retrospective analysis aims to evaluate patient outcome...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-11-01
|
| Series: | Journal of Cancer Research and Clinical Oncology |
| Online Access: | https://doi.org/10.1007/s00432-024-05965-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|